Choueiri TK - Search Results

1

Phase II study of lenalidomide in patients with metastatic renal cell carcinoma.

Choueiri TK, Dreicer R, Rini BI, Elson P, Garcia JA, Thakkar SG, Baz RC, Mekhail TM, Jinks HA, Bukowski RM. Choueiri TK, et al. Cancer. 2006 Dec 1;107(11):2609-16. doi: 10.1002/cncr.22290. Cancer. 2006. PMID: 17075879 Free article. Clinical Trial.

2

An overview of targeted treatments in cancer.

Abou-Jawde R, Choueiri T, Alemany C, Mekhail T. Abou-Jawde R, et al. Clin Ther. 2003 Aug;25(8):2121-37. doi: 10.1016/s0149-2918(03)80209-6. Clin Ther. 2003. PMID: 14512124 Review.

3

Evolving role of pegylated interferons in metastatic renal cell carcinoma.

Choueiri TK, Hutson TE, Bukowski RM. Choueiri TK, et al. Expert Rev Anticancer Ther. 2003 Dec;3(6):823-9. doi: 10.1586/14737140.3.6.823. Expert Rev Anticancer Ther. 2003. PMID: 14686704 Review.

4

Phase I trial of phenoxodiol delivered by continuous intravenous infusion in patients with solid cancer.

Choueiri TK, Mekhail T, Hutson TE, Ganapathi R, Kelly GE, Bukowski RM. Choueiri TK, et al. Ann Oncol. 2006 May;17(5):860-5. doi: 10.1093/annonc/mdl010. Epub 2006 Mar 8. Ann Oncol. 2006. PMID: 16524966 Free article. Clinical Trial.

5

Lenalidomide and pegylated liposomal doxorubicin-based chemotherapy for relapsed or refractory multiple myeloma: safety and efficacy.

Baz R, Walker E, Karam MA, Choueiri TK, Jawde RA, Bruening K, Reed J, Faiman B, Ellis Y, Brand C, Srkalovic G, Andresen S, Knight R, Zeldis J, Hussein MA. Baz R, et al. Among authors: choueiri tk. Ann Oncol. 2006 Dec;17(12):1766-71. doi: 10.1093/annonc/mdl313. Epub 2006 Sep 15. Ann Oncol. 2006. PMID: 16980599 Free article. Clinical Trial.

6

The current role of angiogenesis inhibitors in the treatment of renal cell carcinoma.

Choueiri TK, Bukowski RM, Rini BI. Choueiri TK, et al. Semin Oncol. 2006 Oct;33(5):596-606. doi: 10.1053/j.seminoncol.2006.06.003. Semin Oncol. 2006. PMID: 17045089 Review.

7

Prognostic factors associated with long-term survival in previously untreated metastatic renal cell carcinoma.

Choueiri TK, Rini B, Garcia JA, Baz RC, Abou-Jawde RM, Thakkar SG, Elson P, Mekhail TM, Zhou M, Bukowski RM. Choueiri TK, et al. Ann Oncol. 2007 Feb;18(2):249-55. doi: 10.1093/annonc/mdl371. Epub 2006 Oct 23. Ann Oncol. 2007. PMID: 17060490 Free article.

8

Recombinant human erythropoietin is associated with increased overall survival in patients with multiple myeloma.

Baz R, Walker E, Choueiri TK, Abou Jawde R, Brand C, McGowan B, Yiannaki E, Andresen S, Hussein MA. Baz R, et al. Among authors: choueiri tk. Acta Haematol. 2007;117(3):162-7. doi: 10.1159/000097464. Epub 2006 Dec 5. Acta Haematol. 2007. PMID: 17148935

9

Clinical factors associated with outcome in patients with metastatic clear-cell renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy.

Choueiri TK, Garcia JA, Elson P, Khasawneh M, Usman S, Golshayan AR, Baz RC, Wood L, Rini BI, Bukowski RM. Choueiri TK, et al. Cancer. 2007 Aug 1;110(3):543-50. doi: 10.1002/cncr.22827. Cancer. 2007. PMID: 17577222 Free article.

10

Differential expression of caveolin-1 in renal neoplasms.

Tamaskar I, Choueiri TK, Sercia L, Rini B, Bukowski R, Zhou M. Tamaskar I, et al. Among authors: choueiri tk. Cancer. 2007 Aug 15;110(4):776-82. doi: 10.1002/cncr.22838. Cancer. 2007. PMID: 17594718 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

816 results

Search Page

Filters